Table 1 Mean BRB-N scores in patients with MS and healthy controls
BRB-N | MS patients | Healthy controls | ||
|---|---|---|---|---|
| Â | Raw scores | Standardized scores | Raw scores | Standardized scores |
SRT-LTS | 40.85 ± 17.18 (0–72) | −0.30 ± 1.10 | 50.75 ± 11.68 (14–70) | 0.34 ± 0.75 |
SRT-CLTR | 31.43 ± 18.68 (0–72) | −0.32 ± 1.04 | 43.60 ± 14.58 (2–70) | 0.36 ± 0.81 |
SRT-D | 7.99 ± 3.07 (0–12) | −0.30 ± 1.13 | 9.71 ± 1.87 (5–12) | 0.34 ± 0.69 |
SPART | 18.91 ± 5.51 (5–30) | −0.37 ± 1.00 | 23.26 ± 4.55 (10–30) | 0.42 ± 0.83 |
SPART-D | 6.85 ± 2.34 (0–10) | −0.30 ± 1.05 | 8.26 ± 1.85 (1–12) | 0.34 ± 0.83 |
SDMT | 46.20 ± 15.30 (4–84) | −0.52 ± 0.94 | 64.30 ± 11.24 (37–91) | 0.59 ± 0.69 |
PASAT3 | 40.83 ± 15.44 (0–60) | −0.40 ± 1.14 | 52.45 ± 7.26 (24–60) | 0.45 ± 0.54 |
PASAT2 | 30.18 ± 14.02 (0–60) | −0.41 ± 1.06 | 41.55 ± 8.94 (18–60) | 0.46 ± 0.68 |
WLG | 21.95 ± 7.21 (2–37) | −0.40 ± 1.02 | 27.99 ± 5.29 (12–40) | 0.45 ± 0.75 |